Medical Devices Industry Reports Hemorrhoid Treatment Devices Market | Page 2

REPORT DESCRIPTION
Hemorrhoid Treatment Devices Market – Overview
New product launches is expected to drive the global hemorrhoid treatment devices market size. For instance, in
March 2019, De Scalene launched a new device called Cryocure, an affordable device to treat hemorrhoid without
surgery. Cryocure helps to stop the bleeding from anal blood vessels and constriction of that anal blood vessels.
Furthermore, increasing incidence and prevalence of hemorrhoid disease in the U.S. is expected to drive the
global hemorrhoid treatment devices market growth. For instance, in March 2016, according to the National
Center for Biotechnology Information (NCBI), overall prevalence of hemorrhoid disease in the general population
is around 4.4% and self-reported incidence of hemorrhoid disease is around 10 million persons, annually in the
U.S.
Product recall is the major challenge, which is expected to hamper the global hemorrhoid treatment device market
forecast. For Instance, in September 2016, the U.S. Food and Drug Administration (FDA) recalled the product of
Ultroid Technologies for the Hemorrhoid Management System (UHMS) device kits, procedure packs, including
the Ultroid disposable sterile probes, as these devices had not been designed and manufactured according to the
quality assurance procedures.